HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 293/2/C509    most recent 00098.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (51) Citing Articles via Google Scholar Google Scholar Articles by Schoner, W. Articles by Scheiner-Bobis, G. Search for Related Content PubMed PubMed Citation Articles by Schoner, W. Articles by Scheiner-Bobis, G.

INVITED REVIEW

Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth

Institute of Biochemistry and Endocrinology, Justus Liebig University Giessen, Giessen, Germany

Cardiotonic steroids (CTS), long used to treat heart failure, are endogenously produced in mammals. Among them are the hydrophilic cardenolide ouabain and the more hydrophobic cardenolide digoxin, as well as the bufadienolides marinobufagenin and telecinobufagin. The physiological effects of endogenous ouabain on blood pressure and cardiac activity are consistent with the "Na⁺-lag" hypothesis. This hypothesis assumes that, in cardiac and arterial myocytes, a CTS-induced local increase of Na⁺ concentration due to inhibition of Na⁺/K⁺-ATPase leads to an increase of intracellular Ca²⁺ concentration ([Ca²⁺]_i) via a backward-running Na⁺/Ca²⁺ exchanger. The increase in [Ca²⁺]_i then activates muscle contraction. The Na⁺-lag hypothesis may best explain short-term and inotropic actions of CTS. Yet all data on the CTS-induced alteration of gene expression are consistent with another hypothesis, based on the Na⁺/K⁺-ATPase "signalosome," that describes the interaction of cardiac glycosides with the Na⁺ pump as machinery activating various signaling pathways via intramembrane and cytosolic protein-protein interactions. These pathways, which may be activated simultaneously or selectively, elevate [Ca²⁺]_i, activate Src and the ERK1/2 kinase pathways, and activate phosphoinositide 3-kinase and protein kinase B (Akt), NF-B, and reactive oxygen species. A recent development indicates that new pharmaceuticals with antihypertensive and anticancer activities may be found among CTS and their derivatives: the antihypertensive rostafuroxin suppresses Na⁺ resorption and the Src-epidermal growth factor receptor-ERK pathway in kidney tubule cells. It may be the parent compound of a new principle of antihypertensive therapy. Bufalin and oleandrin or the cardenolide analog UNBS-1450 block tumor cell proliferation and induce apoptosis at low concentrations in tumors with constitutive activation of NF-B.

endogenous cardiotonic steroids; ouabain; marinobufagenin; rostafuroxin; bufalin; oleandrin; sodium pump; sodium/potassium-adenosinetriphosphatase; arterial hypertension; sodium metabolism; cell proliferation; cancer therapy

This article has been cited by other articles:

				J. Zhang, J. M. Hamlyn, E. Karashima, H. Raina, J. R. H. Mauban, M. Izuka, R. Berra-Romani, A. Zulian, W. G. Wier, and M. P. Blaustein Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H1140 - H1150. [Abstract] [Full Text] [PDF]

				Z. Wang, M. Zheng, Z. Li, R. Li, L. Jia, X. Xiong, N. Southall, S. Wang, M. Xia, C. P. Austin, et al. Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK Inhibition Cancer Res., August 15, 2009; 69(16): 6556 - 6564. [Abstract] [Full Text] [PDF]

				C. Antczak, C. Kloepping, C. Radu, T. Genski, L. Muller-Kuhrt, K. Siems, E. de Stanchina, D. H. Abramson, and H. Djaballah Revisiting Old Drugs as Novel Agents for Retinoblastoma: In Vitro and In Vivo Antitumor Activity of Cardenolides Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3065 - 3073. [Abstract] [Full Text] [PDF]

				L. V. Fedorova, V. Raju, N. El-Okdi, A. Shidyak, D. J. Kennedy, S. Vetteth, D. R. Giovannucci, A. Y. Bagrov, O. V. Fedorova, J. I. Shapiro, et al. The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition Am J Physiol Renal Physiol, April 1, 2009; 296(4): F922 - F934. [Abstract] [Full Text] [PDF]

				A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38. [Abstract] [Full Text] [PDF]

				P. Bie, S. Molstrom, and S. Wamberg Normotensive sodium loading in conscious dogs: regulation of renin secretion during {beta}-receptor blockade Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R428 - R435. [Abstract] [Full Text] [PDF]

				S. Scapin, S. Leoni, S. Spagnuolo, A. M. Fiore, and S. Incerpi Short-term effects of thyroid hormones on Na+-K+-ATPase activity of chick embryo hepatocytes during development: focus on signal transduction Am J Physiol Cell Physiol, January 1, 2009; 296(1): C4 - C12. [Abstract] [Full Text] [PDF]

				J. H. Kaplan A Natriuretic Hormone-Binding Site on the Sodium Pump J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1839 - 1840. [Full Text] [PDF]

				W. Schoner and G. Scheiner-Bobis Role of endogenous cardiotonic steroids in sodium homeostasis Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2723 - 2729. [Full Text] [PDF]

				K. J. Sweadner A third mode of ouabain signaling. Focus on "Regulation of ERK1/2 by ouabain and Na-K-ATPase-dependent energy utilization and AMPK activation in parotid acinar cells" Am J Physiol Cell Physiol, September 1, 2008; 295(3): C588 - C589. [Full Text] [PDF]

				C. L. Quinlan, A. D. T. Costa, C. L. Costa, S. V. Pierre, P. Dos Santos, and K. D. Garlid Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H953 - H961. [Abstract] [Full Text] [PDF]

				P. Stoilov, C.-H. Lin, R. Damoiseaux, J. Nikolic, and D. L. Black A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators PNAS, August 12, 2008; 105(32): 11218 - 11223. [Abstract] [Full Text] [PDF]

				J. Tian and Z.-j. Xie The Na-K-ATPase and Calcium-Signaling Microdomains Physiology, August 1, 2008; 23(4): 205 - 211. [Abstract] [Full Text] [PDF]

				D. E. Anderson, O. V. Fedorova, C. H. Morrell, D. L. Longo, V. A. Kashkin, J. D. Metzler, A. Y. Bagrov, and E. G. Lakatta Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1248 - R1254. [Abstract] [Full Text] [PDF]

				R. A. Newman, P. Yang, A. D. Pawlus, and K. I. Block Cardiac Glycosides as Novel Cancer Therapeutic Agents Mol. Interv., February 1, 2008; 8(1): 36 - 49. [Abstract] [Full Text] [PDF]

				L. Liu, X. Zhao, S. V. Pierre, and A. Askari Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1489 - C1497. [Abstract] [Full Text] [PDF]